Tudor Investment Corp’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-14,839
Closed -$108K 1292
2018
Q3
$108K Hold
14,839
﹤0.01% 1020
2018
Q2
$55K Hold
14,839
﹤0.01% 1001
2018
Q1
$57K Hold
14,839
﹤0.01% 947
2017
Q4
$53K Hold
14,839
﹤0.01% 1042
2017
Q3
$59K Buy
14,839
+2,588
+21% +$11.9K ﹤0.01% 1037
2017
Q2
$62K Buy
12,251
+1,046
+9% +$5.88K ﹤0.01% 976
2017
Q1
$77K Sell
11,205
-3,329
-23% -$26K ﹤0.01% 1322
2016
Q4
$136K Buy
14,534
+2,480
+21% +$22.3K ﹤0.01% 1281
2016
Q3
$118K Buy
12,054
+893
+8% +$12K ﹤0.01% 1324
2016
Q2
$158K Sell
11,161
-1,732
-13% -$27K ﹤0.01% 1455
2016
Q1
$180K Buy
12,893
+1,143
+10% +$16.8K ﹤0.01% 1527
2015
Q4
$240K Buy
+11,750
New +$181K 0.01% 1350
2015
Q3
Sell
-11,044
Closed -$169K 1804
2015
Q2
$169K Buy
+11,044
New +$212K ﹤0.01% 1367

Other funds holding AGTC

Tudor Investment Corp's AGTC Position: Q4 2018 in Review

Tudor Investment Corp sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2018, closing a stake of 14,839 shares — an estimated $108K sold.

Tudor Investment Corp first reported a position in AGTC in Q2 2015 and held it in 13 quarters. The position peaked at $240K in Q4 2015. 54 funds tracked by Wall St. Rank hold AGTC as of Q4 2018.

  • Tudor Investment Corp reported no remaining Applied Genetic Technologies Corporation position as of Q4 2018 after selling out during the quarter.
  • Tudor Investment Corp sold 14,839 Applied Genetic Technologies Corporation shares in Q4 2018, an estimated $108K.
  • Tudor Investment Corp first reported a position in Applied Genetic Technologies Corporation in Q2 2015 and held it in 13 quarters.
  • Tudor Investment Corp's Applied Genetic Technologies Corporation position peaked at $240K in Q4 2015.
  • 54 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2018.

Based on Tudor Investment Corp's 13F filing for Q4 2018, filed 14 Feb 2019.